Umbrella-Stiftung Novartis

Address

Umbrella-Stiftung Novartis
Lichtstr. 35
c/o Novartis AG
4056 Basel

Complete data

website n.a. (business owner? add website)

Commercial register ID for Umbrella-Stiftung Novartis: CH-270.7.001.530-8

Unique enterprise identification number (UID) for Umbrella-Stiftung Novartis: CHE-111.973.462

VAT for Umbrella-Stiftung Novartis: CHE-111.973.462 MWST

About the company Umbrella-Stiftung Novartis

Umbrella-Stiftung Novartis, based in Basel, is a company in Switzerland. Umbrella-Stiftung Novartis is active according to the commercial register. The company with the UID number CHE-111.973.462 was founded on 03/28/1949.

For Umbrella-Stiftung Novartis, a total of 5 official reports from the Swiss Official Gazette (SOGC) have been published on sogc.help.ch since January 2007. You can see the latest publication by company Umbrella-Stiftung Novartis from 09/05/2023 on this link.

Purpose of the company Umbrella-Stiftung Novartis

The purpose of the company Umbrella-Stiftung Novartis in Basel is as follows. Supplement to pension benefits for the employees of the founding company and of companies that are economically linked to the Novartis Group (hereinafter referred to as the Novartis Group). The foundation's assets and its earnings are to be used to compensate for reductions in benefits as a result of foreign assignments in the field of state and company pension schemes in the event of old age, illness, accident, disability and death to active and former employees of the Novartis Group as well as their relatives and surviving dependents become.

The company Umbrella-Stiftung Novartis in Basel is listed on Yellowpages.swiss. Latitude and longitude coordinates for Umbrella-Stiftung Novartis are: 47.5733695 and 7.5779534. The unique identification number of this portrait is CHE-111.973.462.

Which companies are available at the same address? In addition to Umbrella-Stiftung Novartis, there are other active companies at the same address Lichtstr. 35, 4056 Basel. This includes the companies Novartis AG| Novartis International AG| Japat AG.